PlainRecalls
FDA Devices Moderate Class II Ongoing

FilmArray NGDS Warrior Panel NGDS-ASY-0007 is a qualitative, multiplexed, nucleic acid-based in vitro diagnostic test intended for use with the FilmArray 2.0 system.

Reported: October 1, 2025 Initiated: July 10, 2025 #Z-2609-2025

Product Description

FilmArray NGDS Warrior Panel NGDS-ASY-0007 is a qualitative, multiplexed, nucleic acid-based in vitro diagnostic test intended for use with the FilmArray 2.0 system.

Reason for Recall

FilmArray NGDS Warrior Panel (NGDS-ASY-0007) has an increased risk of internal control failures when testing positive blood culture, which may lead to delayed results and additional diagnostic workup.

Details

Recalling Firm
Biofire Defense
Units Affected
130 Kits
Distribution
US Nationwide distribution in the states of AL, AZ, UT, CA, TX, DC , VA, FL, MD, OH, HI, NY, KY, LA, MA, MI, MN, MO, NC, NH, RI, NV, TN, IA, WA.
Location
Salt Lake City, UT

Frequently Asked Questions

What product was recalled?
FilmArray NGDS Warrior Panel NGDS-ASY-0007 is a qualitative, multiplexed, nucleic acid-based in vitro diagnostic test intended for use with the FilmArray 2.0 system.. Recalled by Biofire Defense. Units affected: 130 Kits.
Why was this product recalled?
FilmArray NGDS Warrior Panel (NGDS-ASY-0007) has an increased risk of internal control failures when testing positive blood culture, which may lead to delayed results and additional diagnostic workup.
Which agency issued this recall?
This recall was issued by the FDA Devices on October 1, 2025. Severity: Moderate. Recall number: Z-2609-2025.